Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot Q9NVV9: Variant p.Asn75Ile

THAP domain-containing protein 1
Gene: THAP1
Feedback?
Variant information Variant position: help 75 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Asparagine (N) to Isoleucine (I) at position 75 (N75I, p.Asn75Ile). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from medium size and polar (N) to medium size and hydrophobic (I) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help -3 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In DYT6. Any additional useful information about the variant.


Sequence information Variant position: help 75 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 213 The length of the canonical sequence.
Location on the sequence: help SEHFTPDCFKRECNNKLLKE N AVPTIFLCTEPHDKKEDLLE The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         SEHFTPDCFKRECNNKLLKENAVPTIFLCTEPHDKKEDLLE

Mouse                         SEHFTPDCFKRECNNKLLKENAVPTIFLYIEPHEKKEDLES

Rat                           SEHFTPDCFKRECNNKLLKENAVPTIFLYIEPHEKKEELEP

Bovine                        SEHFTPDCFKRECNNKLLKEDAVPTIFLCTEPHDKKEDLLE

Xenopus tropicalis            SDHFTADCFKRECNNKLLKDNAVPTIFAHTEIKKKSGKAVK

Zebrafish                     SQHFTSDCFKQECNNRVLKDNAVPSLFTLQTQDPFSADVCF
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 213 THAP domain-containing protein 1
Zinc finger 1 – 81 THAP-type
Alternative sequence 54 – 213 Missing. In isoform 2.
Mutagenesis 55 – 55 S -> A. Does not affect DNA-binding.
Mutagenesis 57 – 57 H -> A. Abolishes DNA- and zinc-binding.
Mutagenesis 58 – 58 F -> A. Abolishes DNA- and zinc-binding.
Mutagenesis 78 – 78 P -> A. Abolishes DNA- and zinc-binding.



Literature citations
Clinical and genetic evaluation of DYT1 and DYT6 primary dystonia in China.
Cheng F.B.; Wan X.H.; Feng J.C.; Wang L.; Yang Y.M.; Cui L.Y.;
Eur. J. Neurol. 18:497-503(2011)
Cited for: VARIANTS DYT6 ILE-75 AND PRO-150; THAP1/DYT6 sequence variants in non-DYT1 early-onset primary dystonia in China and their effects on RNA expression.
Cheng F.B.; Ozelius L.J.; Wan X.H.; Feng J.C.; Ma L.Y.; Yang Y.M.; Wang L.;
J. Neurol. 259:342-347(2012)
Cited for: VARIANTS DYT6 PHE-54; ILE-75; PRO-150 AND SER-180;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.